The DOI matches its Crossref record; 46 of the 46 references it cites were found in a registry or an index.
Metabolic and psychiatric effects of acyl coenzyme A binding protein (ACBP)/diazepam binding inhibitor (DBI)
Open accessAbstract
Acyl coenzyme A binding protein (ACBP), also known as diazepam binding inhibitor (DBI) is a multifunctional protein with an intracellular action (as ACBP), as well as with an extracellular role (as DBI). The plasma levels of soluble ACBP/DBI are elevated in human obesity and reduced in anorexia nervosa. Accumulating evidence indicates that genetic or antibody-mediated neutralization of ACBP/DBI has anorexigenic effects, thus inhibiting food intake and inducing lipo-catabolic reactions in mice. A number of anorexiants have been withdrawn from clinical development because of their side effects including an increase in depression and suicide. For this reason, we investigated the psychiatric impact of ACBP/DBI in mouse models and patient cohorts. Intravenously (i.v.) injected ACBP/DBI protein conserved its orexigenic function when the protein was mutated to abolish acyl coenzyme A binding, but lost its appetite-stimulatory effect in mice bearing a mutation in the γ2 subunit of the γ-aminobutyric acid (GABA) A receptor (GABA A R). ACBP/DBI neutralization by intraperitoneal (i.p.) injection of a specific mAb blunted excessive food intake in starved and leptin-deficient mice, but not in ghrelin-treated animals. Neither i.v. nor i.p. injected anti-ACBP/DBI antibody affected the behavior of mice in the dark–light box and open-field test. In contrast, ACBP/DBI increased immobility in the forced swim test, while anti-ACBP/DBI antibody counteracted this sign of depression. In patients diagnosed with therapy-resistant bipolar disorder or schizophrenia, ACBP/DBI similarly correlated with body mass index (BMI), not with the psychiatric diagnosis. Patients with high levels of ACBP/DBI were at risk of dyslipidemia and this effect was independent from BMI, as indicated by multivariate analysis. In summary, it appears that ACBP/DBI neutralization has no negative impact on mood and that human depression is not associated with alterations in ACBP/DBI concentrations.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures






Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“and obesity is associated with increased plasma levels of autophagy‐inhibitory factors including DBI/ACBP, both in humans and in mice (Bravo‐San Pedro et al, 2019; Joseph et al, 2020).”
From Autophagy in major human diseases (2021) · cites this paper as Joseph et al, 2020
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The metabolic syndrome—a new worldwide definition
Alberti, K. G. M., Zimmet, P., & Shaw, J. (2005) · The Lancet · doi:10.1016/s0140-6736(05)67402-8 · Cited by 9,352
Inflammation, metaflammation and immunometabolic disorders
Hotamisligil, G. S. (2017) · Nature · doi:10.1038/nature21363 · Cited by 2,570 · cited 1×
“Intriguingly, obesity is coupled to a state of chronic in fl ammation in which TNF α is elevated, contributing to the development of insulin-resistant (type-2) diabetes 5,6 .”
Setiawan, E., Wilson, A. A., Mizrahi, R., Rusjan, P. M., Miler, L., Rajkowska, G., Suridjan, I., Kennedy, J. L., Rekkas, P. V., Houle, S., et al. (2015) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2014.2427 · Cited by 939
Beyond classical benzodiazepines: novel therapeutic potential of GABAA receptor subtypes
Rudolph, U., & Knoflach, F. (2011) · Nature Reviews Drug Discovery · doi:10.1038/nrd3502 · Cited by 733
Guidotti, A., Forchetti, C. M., Corda, M. G., Konkel, D., Bennett, C. D., & Costa, E. (1983) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.80.11.3531 · Cited by 644 · cited 1×
“Intracerebroventricular administration of recombinant ACBP/DBI or that of ACBP/DBI-derived neuropeptides induces procon fl ict behavior 40 , stimulates anxiety 41 , and reduces food intake 42 , causing a loss in bodyweight in long-term experiments 43 .”
Animal Models of Depression: Molecular Perspectives
Krishnan, V., & Nestler, E. J. (2011) · Current Topics in Behavioral Neurosciences · doi:10.1007/7854_2010_108 · Cited by 528 · cited 2×
“Test based on the observation that rodents, after initial escape-oriented movements, develop an immobile posture when placed in an inescapable stressful situation 23 .”
Current pharmacotherapy for obesity
Srivastava, G., & Apovian, C. M. (2018) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2017.122 · Cited by 397
Manjithaya, R., Anjard, C., Loomis, W. F., & Subramani, S. (2010) · Journal of Cell Biology · doi:10.1083/jcb.200911149 · Cited by 337 · cited 2×
“These fi ndings, combined with the fact that ACBP/DBI, an evolutionarily ancient gene/protein, can stimulate sporulation in unicellular yeast species 7,8 and in slime moldsan 9 , pharyngeal pumping in nematodes 8 , and mouse hook movement (the equivalent of mastication) in fl ies 10 let us to…”
Rudolph, U., & Möhler, H. (2014) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-011613-135947 · Cited by 319
The Open Field Test: reinventing the wheel
Stanford, S. C. (2007) · Journal of Psychopharmacology · doi:10.1177/0269881107073199 · Cited by 317 · cited 1×
“The open-fi eld test, which measures general locomotor activity levels, anxiety, and willingness to explore, is known to be sensitive to benzodiazepines 32 – 34 .”
Cited by
Autophagy in major human diseases
Klionsky, D. J., Petroni, G., Amaravadi, R. K., Baehrecke, E. H., Ballabio, A., Boya, P., Bravo‐San Pedro, J. M., Cadwell, K., Cecconi, F., Choi, A. M. K., et al. (2021) · The EMBO Journal · doi:10.15252/embj.2021108863 · Cited by 1,585
Self-citationMotiño, O., Lambertucci, F., Anagnostopoulos, G., Li, S., Nah, J., Castoldi, F., Senovilla, L., Montégut, L., Chen, H., Durand, S., et al. (2022) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2207344119 · Cited by 56
Self-citationMontégut, L., Joseph, A., Chen, H., Abdellatif, M., Ruckenstuhl, C., Motiño, O., Lambertucci, F., Anagnostopoulos, G., Lachkar, S., Dichtinger, S., et al. (2022) · Aging Cell · doi:10.1111/acel.13751 · Cited by 47
“Indeed, in humans, ACBP/DBI concentrations in the plasma increase with age (Joseph et al., 2021), as well as with BMI (Joseph et al., 2021, 2020), which is a risk factor for accelerated aging (López- Otín et al., 2016; López- Otín & Kroemer, 2021).”
BackgroundSelf-citationOld Paradoxes and New Opportunities for Appetite Control in Obesity
Montégut, L., López-Otín, C., Magnan, C., & Kroemer, G. (2021) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2021.02.005 · Cited by 48
Self-citationAcyl coenzyme A binding protein ( ACBP ): An aging‐ and disease‐relevant “autophagy checkpoint”
Montégut, L., Abdellatif, M., Motiño, O., Madeo, F., Martins, I., Quesada, V., López-Otín, C., & Kroemer, G. (2023) · Aging Cell · doi:10.1111/acel.13910 · Cited by 44
Self-citation
Metadata
- Authors
- Joseph, A., Moriceau, S., Sica, V., Anagnostopoulos, G., Pol, J., Martins, I., Lafarge, A., Maiuri, M. C., Leboyer, M., Loftus, J., Bellivier, F., Belzeaux, R., Berna, F., Etain, B., Capdevielle, D., Courtet, P., Dubertret, C., Dubreucq, J., Thierry, D. A., Fond, G., Gard, S., Llorca, P.-M., Mallet, J., Misdrahi, D., Olié, E., Passerieux, C., Polosan, M., Roux, P., Samalin, L., Schürhoff, F., Schwan, R., the FACE-SZ and FACE-BD (FondaMental Academic Centers of Expertise, F. S. A. F. B. D. G., Magnan, C., Oury, F., Bravo-San Pedro, J. M., & Kroemer, G.
- Affiliations
- Inserm (FR)
- Hôpital Necker-Enfants Malades (FR)
- Fondation FondaMental (FR)
- Aix-Marseille Université (FR)
- Université Clermont Auvergne (FR)
- Karolinska University Hospital (SE)
- Corresponding author
- Kroemer, Guido
- ORCID
- Joseph, Adrien
- Moriceau, Stéphanie
- Sica, Valentina
- Anagnostopoulos, Gerasimos
- Pol, Jonathan
- Martins, Isabelle
- Lafarge, Antoine
- Maiuri, Maria Chiara
- Leboyer, Marion
- Bellivier, Frank
- Berna, Fabrice
- Capdevielle, Delphine
- Courtet, Philippe
- Dubertret, Caroline
- Dubreucq, Julien
- Fond, Guillaume
- Llorca, Pierre-Michel
- Mallet, Jasmina
- Misdrahi, David
- Passerieux, Christine
- Polosan, Mircea
- Roux, Paul
- Samalin, Ludovic
- Schürhoff, Franck
- Oury, Franck
- Kroemer, Guido
- Venue
- Cell Death & Disease
- Published
- 2020-07-06
- Volume
- 11
- Issue
- 7
- Pages
- 502-502
- ISSN
- 2041-4889 (ISSN-L)
- PMC
- PMC7338362
- OpenAlex
- W3038745725
- Cited by
- 44
- References
- 46
- Citations by year
- 2026: 4 · 2025: 14 · 2024: 9 · 2023: 5 · 2022: 5 · 2021: 6 · 2020: 1
- FWCI
- 2.18
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/4.0 (tdm)
- creativecommons.org/licenses/by/4.0 (vor)
- Locations
- Cell Death and Disease (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- HAL (submittedVersion, cc-by)
- Funders
- Association pour la Recherche sur le Cancer (ANR-18-IDEX-0001)
- Seerave Foundation
- E-Rare
- Fondation FondaMental
- European Commission (HORIZON2020)
- Agence Nationale de la Recherche (ANR-17-CE14-0030, UMS3655, ANR-10-COHO-0010, ANR18, ANR-19-CE14-0004, E-Rare-2, ANR-16-RHUS-0008, ANR-18-IDEX-0001)
- Fondation Leducq
- Institut National de la Santé et de la Recherche Médicale (ANR-18-IDEX-0001)
- Fondation pour la Recherche Médicale
- Ligue Contre le Cancer
- Centre National de la Recherche Scientifique (#ANR-18-IDEX-0001, UMS3655)
- Institut Universitaire de France (ANR-18-IDEX-0001)
- Institut National Du Cancer (#ANR-18-IDEX-0001)
- Institut Gustave-Roussy (UMS3655)
- European Research Area Network on Cardiovascular Diseases
- High-end Foreign Experts Recruitment Plan of China (GDW20171100085)
- Labex Immuno-Oncology ((ANR-18-IDEX-0001))
- Topics
- Life Sciences › Neuroscience › Endocrine and Autonomic Systems › Regulation of Appetite and Obesity
- Social Sciences › Psychology › Clinical Psychology › Eating Disorders and Behaviors
- Health Sciences › Medicine › Pharmacology (medical) › Pharmacology and Obesity Treatment
- Keywords
- diazepam binding inhibitor, appetite regulation, dietary intake, obesity, anorexia nervosa, depression, forced swim test, GABAA receptor, leptin, ghrelin, dyslipidemia, body mass index, bipolar disorder, schizophrenia
- MeSH terms
- Animals, Appetite, Behavior, Animal, Mental Disorders, Darkness, Feeding Behavior, Immobilization, Male, Mice, Inbred C57BL, Receptors, GABA-A, Swimming, Body Mass Index, Metabolic Syndrome, Diazepam Binding Inhibitor
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Metabolic and psychiatric effects of acyl coenzyme A binding protein (ACBP)/diazepam binding inhibitor (DBI). https://app.cochat.ai/papers/10.1038/s41419-020-2716-5
- The paper
- Joseph, A., Moriceau, S., Sica, V., Anagnostopoulos, G., Pol, J., Martins, I., Lafarge, A., Maiuri, M. C., Leboyer, M., Loftus, J., Bellivier, F., Belzeaux, R., Berna, F., Etain, B., Capdevielle, D., Courtet, P., Dubertret, C., Dubreucq, J., Thierry, D. A., . . . Kroemer, G. (2020). Metabolic and psychiatric effects of acyl coenzyme A binding protein (ACBP)/diazepam binding inhibitor (DBI). Cell Death & Disease. https://doi.org/10.1038/s41419-020-2716-5
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.